Websites, domains, hosts that links to zinbryta.com
Our database shows, that the website zinbryta.com is linked by a total of 9 websites.
Number of websites/domains displayed: 9
Results found: 9
Websites discovered:
Biogen | Neurological and Neurodegenerative Diseaseshttp://pageoverview.com/website-report/biogenidec.com
Through cutting-edge science and medicine, Biogen discovers, develops and delivers worldwide innovative therapies for people living with serious neurological and neurodegenerative diseases.
- Expected expiration: June 23rd in 2017
- Creation date: June 23rd in 2003
- Renew date: June 19th in 2016
ZINBRYTA® (daclizumab) for Healthcare Professionalshttp://pageoverview.com/website-report/zinbrytahcp.com
Learn about ZINBRYTA® (daclizumab), an injection treatment. Find information to determine if it’s the right option for patients. See full ISI & Boxed Warning.
- Expected expiration: August 19th in 2018
- Creation date: August 19th in 2014
- Renew date: August 15th in 2017
AVONEX® (interferon beta-1a)http://pageoverview.com/website-report/avonex.com
Find out more information about AVONEX® (interferon beta-1a), including how it is thought to work, how to take it and how to get started.
- Expected expiration: October 12th in 2017
- Creation date: October 13th in 1995
- Renew date: October 8th in 2016
PLEGRIDY® (peginterferon beta-1a)http://pageoverview.com/website-report/plegridy.com
Learn more about the benefits and risks with PLEGRIDY® (peginterferon beta-1a) and how to get started.
- Expected expiration: January 18th in 2018
- Creation date: January 18th in 2012
- Renew date: January 14th in 2017
ZINBRYTA® (daclizumab)http://pageoverview.com/website-report/zinbryta.com
Consider once-a-month ZINBRYTA® (daclizumab) if you’re looking for another treatment option. Find instructional videos & more here. See full safety & Boxed Warning.
- Expected expiration: September 6th in 2018
- Creation date: September 6th in 2013
- Renew date: September 2nd in 2017
TYSABRI® (natalizumab)http://pageoverview.com/website-report/tysabri.com
Learn about TYSABRI® (natalizumab), a prescription medicine for adults, including dosing information, how it works, copay information and support resources.
- Expected expiration: October 11th in 2017
- Creation date: October 11th in 2002
- Renew date: October 7th in 2016
Relapsing Multiple Sclerosis Treatment Options From Biogenhttp://pageoverview.com/website-report/biogenoptions.com
Learn about Biogen treatment options for people living with relapsing multiple sclerosis (MS).
- Expected expiration: March 27th in 2018
- Creation date: March 27th in 2015
- Renew date: March 23rd in 2017
Biogen | Neurological and Neurodegenerative Diseaseshttp://pageoverview.com/website-report/biogen.com
Through cutting-edge science and medicine, Biogen discovers, develops and delivers worldwide innovative therapies for people living with serious neurological and neurodegenerative diseases.
- Expected expiration: April 15th in 2018
- Creation date: April 14th in 1995
- Renew date: April 11th in 2017
Tecfidera® (dimethyl fumarate)http://pageoverview.com/website-report/tecfidera.com
Discover Tecfidera® (dimethyl fumarate). Get information on clinical studies, a copay program, and patient support services.
- Expected expiration: October 23rd in 2017
- Creation date: October 23rd in 2012
- Renew date: November 25th in 2016
- AddThis User: ra-583ee685905deb55